Guardian Pharmacy Services (NYSE:GRDN) Stock Rating Upgraded by Zacks Research

Guardian Pharmacy Services (NYSE:GRDN) was upgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research note issued on Wednesday,Zacks.com reports.

GRDN has been the topic of several other reports. Truist Financial upped their price objective on shares of Guardian Pharmacy Services from $34.00 to $38.00 and gave the stock a “buy” rating in a report on Thursday, March 12th. UBS Group reissued a “buy” rating on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Weiss Ratings restated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research note on Monday, December 29th. Raymond James Financial restated an “outperform” rating and set a $40.00 price target on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Finally, Oppenheimer boosted their price objective on Guardian Pharmacy Services from $35.00 to $38.00 and gave the company an “outperform” rating in a report on Thursday, March 12th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $38.00.

Guardian Pharmacy Services Trading Up 1.5%

Shares of NYSE:GRDN opened at $34.43 on Wednesday. The company has a market capitalization of $2.18 billion, a price-to-earnings ratio of 44.72 and a beta of 0.86. Guardian Pharmacy Services has a 12-month low of $19.17 and a 12-month high of $37.43. The business has a 50-day moving average price of $32.14 and a 200 day moving average price of $29.60.

Guardian Pharmacy Services (NYSE:GRDN) last posted its earnings results on Wednesday, March 11th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.10. The company had revenue of $397.62 million for the quarter, compared to analysts’ expectations of $390.04 million. Guardian Pharmacy Services had a net margin of 3.40% and a return on equity of 31.64%. The business’s revenue was up 17.4% compared to the same quarter last year. As a group, equities research analysts predict that Guardian Pharmacy Services will post 0.87 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Dynamic Technology Lab Private Ltd acquired a new position in shares of Guardian Pharmacy Services in the first quarter worth $233,000. Envestnet Asset Management Inc. boosted its holdings in Guardian Pharmacy Services by 7.1% in the second quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock valued at $258,000 after purchasing an additional 805 shares during the period. Geode Capital Management LLC grew its stake in Guardian Pharmacy Services by 65.9% during the 2nd quarter. Geode Capital Management LLC now owns 336,701 shares of the company’s stock worth $7,177,000 after purchasing an additional 133,715 shares in the last quarter. Police & Firemen s Retirement System of New Jersey increased its holdings in Guardian Pharmacy Services by 76.8% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock worth $52,000 after purchasing an additional 1,062 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Guardian Pharmacy Services in the 2nd quarter valued at about $346,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.